
0:00
43:07
The results of the midterm elections could swing control of Congress — with a range of potential impacts for biopharma, from the US posture towards China to drug pricing. After the results are called, we’ll be live with regular guest and DC politics and policy expert Nick Shipley talking about what the vote means for the biotech and pharma industry.
Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D
Flere episoder fra "Post-Hoc Live"



Gå ikke glip af nogen episoder af “Post-Hoc Live” - abonnér på podcasten med gratisapp GetPodcast.








